Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of patients with hematologic malignancies (HMs) or hema...

Descripción completa

Detalles Bibliográficos
Autores principales: Axell-House, Dierdre B., Wurster, Sebastian, Jiang, Ying, Kyvernitakis, Andreas, Lewis, Russell E., Tarrand, Jeffrey J., Raad, Issam I., Kontoyiannis, Dimitrios P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002622/
https://www.ncbi.nlm.nih.gov/pubmed/33802827
http://dx.doi.org/10.3390/jof7030217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002622/
https://www.ncbi.nlm.nih.gov/pubmed/33802827
http://dx.doi.org/10.3390/jof7030217

Ejemplares similares